Blake Mandell is the founder of Transcend Therapeutics. Transcend Therapeutics has raised $42M in total funding. Latest round: Series A.
Blake Mandell is the Co-Founder and CEO of Transcend Therapeutics, a clinical-stage neuroscience-focused biopharmaceutical company. He co-founded the company to develop non-hallucinogenic MDMA analogues for neuropsychiatric conditions like PTSD. Under his leadership, Transcend Therapeutics raised nearly $42 million and secured a Yale–U.S. Department of Defense grant.
Full founder directory · Investor directory · Company funding database · Fundraising library